Table 124.4Treatment of AML in Relapse*

Duration of first CRFrequency of second CR
>2 years61%
11/2–2 years53%
1–11/2 years30%
7–12 months19%
1–6 months10%
Total29% (155/531 pts)
*

Patients received a variety of different reinduction regimens. (Adapted from Rees et al.260)

From: Chapter 124, Acute Myeloid Leukemia in Adults

Cover of Holland-Frei Cancer Medicine
Holland-Frei Cancer Medicine. 5th edition.
Bast RC Jr, Kufe DW, Pollock RE, et al., editors.
Hamilton (ON): BC Decker; 2000.
© 2000, BC Decker Inc.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.